Loading clinical trials...
Loading clinical trials...
A PHASE 3, MULTICENTER, RANDOMIZED, LONG TERM STUDY OF THE SAFETY OF TANEZUMAB IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE OR HIP
Conditions
Interventions
tanezumab
tanezumab
+1 more
Locations
226
United States
Pinncale Research Group, LLC
Anniston, Alabama, United States
Anniston Medical Clinic, PC
Anniston, Alabama, United States
Pinnacle Research Group, LLC
Anniston, Alabama, United States
Greystone Medical Center
Birmingham, Alabama, United States
Saadat Ansari, MD Office
Huntsville, Alabama, United States
Coastal Clinical Research, Inc.
Mobile, Alabama, United States
Start Date
February 6, 2009
Primary Completion Date
November 2, 2010
Completion Date
June 23, 2011
Last Updated
May 10, 2021
NCT07551245
NCT06755697
NCT06702046
NCT07217405
NCT05986292
NCT06381791
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions